PL02.09 Nintedanib + Pemetrexed/Cisplatin in Patients With Unresectable MPM: Phase III Results From the LUME-Meso Trial
Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.014
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV